MENLO PARK, Calif., May 19 /PRNewswire/ -- Apieron, Inc. (www.apieron.com) significantly strengthened its senior management team with the appointment of Steve Bubrick as Vice President, Sales & Marketing, and Bryan Miller as Vice President, Finance. Both appointments are effective immediately.
Mr. Bubrick has more than 20 years of operational and commercial experience in the consumer medical device industry, mainly in diabetes management. Prior to joining Apieron, Mr. Bubrick was the Vice President of Customer Care & Reimbursement for Bedford, Massachusetts-based Insulet Corp., where he contributed to the company's 170% revenue growth in 2008. Before joining Insulet, Mr. Bubrick was Director, Worldwide Marketing for in-vivo products at Abbott Diabetes Care, which was formed by Abbott's acquisition of TheraSense, at which he was a commercial and R&D director. Prior to TheraSense, Mr. Bubrick held numerous commercial and international roles at LifeScan Inc., a division of Johnson & Johnson. Steve earned his BA at the
"We see many parallels between the self glucose testing and eNO monitoring markets," said Holly McGarraugh, Apieron CEO. "Steve understands how to grow a start up business like Apieron through great marketing and customer relations. His leadership will play a strategically important role in understanding our markets, serving our customers and driving sales of the Insight eNO System. With Bryan filling a critical financial leadership role, and Steve joining us to focus our commercial efforts, we've significantly increased the depth and experience on the senior management team."
Mr. Miller most recently served as a Principal at Berkshire Financial Management LLC where he handled financial and management consulting and equity management of properties in California, Nevada and Arizona. Prior to that, Mr. Miller was the Senior Director of Finance at eV3, (FoxHollow Technologies, Inc.) the medical device company, where he was responsible for financial planning, forecasting and analysis as well as internal reporting. Mr. Miller has an extensive background in financial leadership roles, having held additional senior positions with Trimble Navigation, Shopping the Globe, Inc. and Sega of America. He earned his MBA at
About the Insight eNO System
The Insight eNO System has been available for use in the physicians' office since March 2008. The system uses a proprietary biosensor technology to measure exhaled nitric oxide, a well established indicator of asthma severity and steroid responsive airway inflammation. Measuring eNO and determining the level of airway inflammation can help clinicians more closely manage their patients' asthma and therefore more precisely titrate medications, which can lead to fewer asthma exacerbations.
About Apieron Inc.
Apieron Inc. is a private, venture-backed medical device company based in Menlo Park, CA that was formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) for the management of asthma. The Apieron biosensor technology platform utilizes a patented technology that allows for the highly sensitive detection of selected analytes like eNO. Apieron is committed to collaborating with physicians and patients to develop innovative medical solutions to improve quality of life and standards of care.
Contact: Steve DiMattia (646) 201-5445
|SOURCE Apieron, Inc.|
Copyright©2009 PR Newswire.
All rights reserved